(Q46417040)

22 December 2017

title

Association of ADIPOR2 with liver function tests in type 2 diabetic subjects (English)

1 reference

22 December 2017

author

Elías Delgado Álvarez

4

1 reference

22 December 2017

Maria García-Gil

5

1 reference

22 December 2017

Wifredo Ricart

7

1 reference

22 December 2017

José Manuel Fernández-Real

8

1 reference

22 December 2017

author name string

Abel López-Bermejo

1

1 reference

22 December 2017

Patricia Botas-Cervero

2

1 reference

22 December 2017

Francisco Ortega-Delgado

3

1 reference

22 December 2017

Tohru Funahashi

6

1 reference

22 December 2017

publication date

24 July 2008

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

2308-2313

1 reference

22 December 2017

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin, hepatocellular dysfunction and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Prevalence of diabetes mellitus and glucose intolerance in the population aged 30 to 75 years in Asturias, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin and its receptors: partners contributing to the "vicious circle" leading to the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Opposing effects of adiponectin receptors 1 and 2 on energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Serum visfatin increases with progressive beta-cell deterioration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

The evolving role of leptin and adiponectin in chronic liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.344

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.344

1 reference

22 December 2017

1 reference

22 December 2017